Marksans Pharma has informed about a Press Release dated October 18, 2016 titled ‘Marksans Pharma Limited announces USFDA approval for Paricalcitol Capsules 1 mcg, 2 mcg and 4 mcg (ANDA 204948)’.
The above information is a part of company’s filings submitted to BSE.